Neurolymphomatosis: an international primary CNS lymphoma collaborative group report S Grisariu, B Avni, TT Batchelor, MJ van den Bent, F Bokstein, D Schiff, ... Blood, The Journal of the American Society of Hematology 115 (24), 5005-5011, 2010 | 339 | 2010 |
Leptomeningeal metastases from solid tumors: A comparison of two prospective series treated with and without intra‐cerebrospinal fluid chemotherapy F Bokstein, A Lossos, T Siegal Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 213 | 1998 |
In vivo assessment of the window of barrier opening after osmotic blood—brain barrier disruption in humans T Siegal, R Rubinstein, F Bokstein, A Schwartz, A Lossos, E Shalom, ... Journal of neurosurgery 92 (4), 599-605, 2000 | 205 | 2000 |
Treatment with bevacizumab and irinotecan for recurrent high‐grade glial tumors F Bokstein, S Shpigel, DT Blumenthal Cancer 112 (10), 2267-2273, 2008 | 179 | 2008 |
Malignant involvement of the spine: assessment by 18F-FDG PET/CT U Metser, H Lerman, A Blank, G Lievshitz, F Bokstein, E Even-Sapir Journal of Nuclear Medicine 45 (2), 279-284, 2004 | 158 | 2004 |
Progressive low‐grade oligodendrogliomas: Response to temozolomide and correlation between genetic profile and O6‐methylguanine DNA methyltransferase … N Levin, I Lavon, B Zelikovitsh, D Fuchs, F Bokstein, Y Fellig, T Siegal Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 153 | 2006 |
Neurologic complications of immune checkpoint inhibitors A Fellner, C Makranz, M Lotem, F Bokstein, A Taliansky, S Rosenberg, ... Journal of neuro-oncology 137, 601-609, 2018 | 146 | 2018 |
Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary … J Glass, M Won, CJ Schultz, D Brat, NL Bartlett, JH Suh, M Werner-Wasik, ... Journal of Clinical Oncology 34 (14), 1620, 2016 | 145 | 2016 |
Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors DT Blumenthal, M Yalon, GW Vainer, A Lossos, S Yust, L Tzach, ... Journal of neuro-oncology 129, 453-460, 2016 | 89 | 2016 |
Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy F Bokstein, A Lossos, IS Lossos, T Siegal Leukemia & lymphoma 43 (3), 587-593, 2002 | 84 | 2002 |
Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study M Artzi, F Bokstein, DT Blumenthal, O Aizenstein, G Liberman, BW Corn, ... European Journal of Radiology 83 (7), 1250-1256, 2014 | 82 | 2014 |
MRI radiomics analysis of molecular alterations in low-grade gliomas B Shofty, M Artzi, D Ben Bashat, G Liberman, O Haim, A Kashanian, ... International journal of computer assisted radiology and surgery 13, 563-571, 2018 | 81 | 2018 |
Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study M Artzi, G Liberman, N Vaisman, F Bokstein, F Vitinshtein, O Aizenstein, ... Journal of neuro-oncology 132, 267-275, 2017 | 77 | 2017 |
Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line? YR Lawrence, DT Blumenthal, D Matceyevsky, AA Kanner, F Bokstein, ... Journal of neuro-oncology 105, 1-7, 2011 | 76 | 2011 |
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood‐brain barrier disruption in patients with brain lymphoma E Zylber‐Katz, JM Gomori, A Schwartz, A Lossos, F Bokstein, T Siegal Clinical Pharmacology & Therapeutics 67 (6), 631-641, 2000 | 70 | 2000 |
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677 EM Ratai, Z Zhang, BS Snyder, JL Boxerman, Y Safriel, RC McKinstry, ... Neuro-oncology 15 (7), 936-944, 2013 | 69 | 2013 |
Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial A Taliansky-Aronov, F Bokstein, I Lavon, T Siegal Journal of neuro-oncology 79, 153-157, 2006 | 69 | 2006 |
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in … BM Ellingson, E Kim, DC Woodworth, H Marques, JL Boxerman, Y Safriel, ... International journal of oncology 46 (5), 1883-1892, 2015 | 55 | 2015 |
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma MR Gilbert, SL Pugh, K Aldape, AG Sorensen, T Mikkelsen, ... Journal of neuro-oncology 131, 193-199, 2017 | 54 | 2017 |
Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF DT Blumenthal, E Shacham-Shmueli, F Bokstein, DS Schmid, RJ Cohrs, ... Neurology 76 (5), 484-485, 2011 | 54 | 2011 |